These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 34637754)
1. NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain. Liu S; Aldinger KA; Cheng CV; Kiyama T; Dave M; McNamara HK; Zhao W; Stafford JM; Descostes N; Lee P; Caraffi SG; Ivanovski I; Errichiello E; Zweier C; Zuffardi O; Schneider M; Papavasiliou AS; Perry MS; Humberson J; Cho MT; Weber A; Swale A; Badea TC; Mao CA; Garavelli L; Dobyns WB; Reinberg D Mol Cell; 2021 Nov; 81(22):4663-4676.e8. PubMed ID: 34637754 [TBL] [Abstract][Full Text] [Related]
2. Rubinstein-Taybi Syndrome and Epigenetic Alterations. Korzus E Adv Exp Med Biol; 2017; 978():39-62. PubMed ID: 28523540 [TBL] [Abstract][Full Text] [Related]
3. Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. Fergelot P; Van Belzen M; Van Gils J; Afenjar A; Armour CM; Arveiler B; Beets L; Burglen L; Busa T; Collet M; Deforges J; de Vries BB; Dominguez Garrido E; Dorison N; Dupont J; Francannet C; Garciá-Minaúr S; Gabau Vila E; Gebre-Medhin S; Gener Querol B; Geneviève D; Gérard M; Gervasini CG; Goldenberg A; Josifova D; Lachlan K; Maas S; Maranda B; Moilanen JS; Nordgren A; Parent P; Rankin J; Reardon W; Rio M; Roume J; Shaw A; Smigiel R; Sojo A; Solomon B; Stembalska A; Stumpel C; Suarez F; Terhal P; Thomas S; Touraine R; Verloes A; Vincent-Delorme C; Wincent J; Peters DJ; Bartsch O; Larizza L; Lacombe D; Hennekam RC Am J Med Genet A; 2016 Dec; 170(12):3069-3082. PubMed ID: 27648933 [TBL] [Abstract][Full Text] [Related]
4. Rubinstein-Taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report. Al-Qattan MM; Jarman A; Rafique A; Al-Hassnan ZN; Al-Qattan HM BMC Med Genet; 2019 Jan; 20(1):12. PubMed ID: 30635043 [TBL] [Abstract][Full Text] [Related]
5. Case report: a Chinese girl like atypical Rubinstein-Taybi syndrome caused by a novel heterozygous mutation of the EP300 gene. Bai Z; Li G; Kong X BMC Med Genomics; 2023 Feb; 16(1):24. PubMed ID: 36797748 [TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular characterization of Rubinstein-Taybi syndrome patients carrying distinct novel mutations of the EP300 gene. Negri G; Milani D; Colapietro P; Forzano F; Della Monica M; Rusconi D; Consonni L; Caffi LG; Finelli P; Scarano G; Magnani C; Selicorni A; Spena S; Larizza L; Gervasini C Clin Genet; 2015 Feb; 87(2):148-54. PubMed ID: 24476420 [TBL] [Abstract][Full Text] [Related]
7. Mutations in CREBBP and EP300 genes affect DNA repair of oxidative damage in Rubinstein-Taybi syndrome cells. Dutto I; Scalera C; Tillhon M; Ticli G; Passaniti G; Cazzalini O; Savio M; Stivala LA; Gervasini C; Larizza L; Prosperi E Carcinogenesis; 2020 May; 41(3):257-266. PubMed ID: 31504229 [TBL] [Abstract][Full Text] [Related]
8. iPSC-derived neurons of CREBBP- and EP300-mutated Rubinstein-Taybi syndrome patients show morphological alterations and hypoexcitability. Alari V; Russo S; Terragni B; Ajmone PF; Sironi A; Catusi I; Calzari L; Concolino D; Marotta R; Milani D; Giardino D; Mantegazza M; Gervasini C; Finelli P; Larizza L Stem Cell Res; 2018 Jul; 30():130-140. PubMed ID: 29883886 [TBL] [Abstract][Full Text] [Related]
9. An AUTS2-Polycomb complex activates gene expression in the CNS. Gao Z; Lee P; Stafford JM; von Schimmelmann M; Schaefer A; Reinberg D Nature; 2014 Dec; 516(7531):349-54. PubMed ID: 25519132 [TBL] [Abstract][Full Text] [Related]
10. Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum. López M; García-Oguiza A; Armstrong J; García-Cobaleda I; García-Miñaur S; Santos-Simarro F; Seidel V; Domínguez-Garrido E BMC Med Genet; 2018 Mar; 19(1):36. PubMed ID: 29506490 [TBL] [Abstract][Full Text] [Related]
11. Screening of a large Rubinstein-Taybi cohort identified many novel variants and emphasizes the importance of the CREBBP histone acetyltransferase domain. Cross E; Duncan-Flavell PJ; Howarth RJ; Hobbs JI; Thomas NS; Bunyan DJ Am J Med Genet A; 2020 Nov; 182(11):2508-2520. PubMed ID: 32827181 [TBL] [Abstract][Full Text] [Related]
12. WDR68 is essential for the transcriptional activation of the PRC1-AUTS2 complex and neuronal differentiation of mouse embryonic stem cells. Wang Q; Geng Z; Gong Y; Warren K; Zheng H; Imamura Y; Gao Z Stem Cell Res; 2018 Dec; 33():206-214. PubMed ID: 30448639 [TBL] [Abstract][Full Text] [Related]
13. EP300 facilitates human trophoblast stem cell differentiation. van Voorden AJ; Keijser R; Veenboer GJM; Lopes Cardozo SA; Diek D; Vlaardingerbroek JA; van Dijk M; Ris-Stalpers C; van Pelt AMM; Afink GB Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2217405120. PubMed ID: 37406095 [TBL] [Abstract][Full Text] [Related]
15. Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology. Viosca J; Lopez-Atalaya JP; Olivares R; Eckner R; Barco A Neurobiol Dis; 2010 Jan; 37(1):186-94. PubMed ID: 19822209 [TBL] [Abstract][Full Text] [Related]
16. From Whole Gene Deletion to Point Mutations of EP300-Positive Rubinstein-Taybi Patients: New Insights into the Mutational Spectrum and Peculiar Clinical Hallmarks. Negri G; Magini P; Milani D; Colapietro P; Rusconi D; Scarano E; Bonati MT; Priolo M; Crippa M; Mazzanti L; Wischmeijer A; Tamburrino F; Pippucci T; Finelli P; Larizza L; Gervasini C Hum Mutat; 2016 Feb; 37(2):175-83. PubMed ID: 26486927 [TBL] [Abstract][Full Text] [Related]
17. Menke-Hennekam syndrome; delineation of domain-specific subtypes with distinct clinical and DNA methylation profiles. Haghshenas S; Bout HJ; Schijns JM; Levy MA; Kerkhof J; Bhai P; McConkey H; Jenkins ZA; Williams EM; Halliday BJ; Huisman SA; Lauffer P; de Waard V; Witteveen L; Banka S; Brady AF; Galazzi E; van Gils J; Hurst ACE; Kaiser FJ; Lacombe D; Martinez-Monseny AF; Fergelot P; Monteiro FP; Parenti I; Persani L; Santos-Simarro F; Simpson BN; ; Alders M; Robertson SP; Sadikovic B; Menke LA HGG Adv; 2024 Jul; 5(3):100287. PubMed ID: 38553851 [TBL] [Abstract][Full Text] [Related]
18. Identical EP300 variant leading to Rubinstein-Taybi syndrome with different clinical and immunologic phenotype. Saettini F; Fazio G; Bonati MT; Moratto D; Massa V; Di Fede E; Castiglioni S; Marchetti D; Chiarini M; Sottini A; Iascone M; Cazzaniga G; Imberti L; Biondi A; Gervasini C; Badolato R Am J Med Genet A; 2022 Jul; 188(7):2129-2134. PubMed ID: 35266289 [TBL] [Abstract][Full Text] [Related]
19. Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndrome. Menke LA; ; Gardeitchik T; Hammond P; Heimdal KR; Houge G; Hufnagel SB; Ji J; Johansson S; Kant SG; Kinning E; Leon EL; Newbury-Ecob R; Paolacci S; Pfundt R; Ragge NK; Rinne T; Ruivenkamp C; Saitta SC; Sun Y; Tartaglia M; Terhal PA; van Essen AJ; Vigeland MD; Xiao B; Hennekam RC Am J Med Genet A; 2018 Apr; 176(4):862-876. PubMed ID: 29460469 [TBL] [Abstract][Full Text] [Related]
20. Rubinstein-Taybi syndrome in Chinese population with four novel mutations. Yu PT; Luk HM; Lo IFM Am J Med Genet A; 2021 Jan; 185(1):267-273. PubMed ID: 33063428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]